The activation of the adaptive immune system: Cross-talk between antigen-presenting cells, T cells and B cells

Immunology Letters

Volumn 162, Issue 2, 2014, Pages 103-112

  den Haan, Joke M M ^a   Arens, Ramon ^b   van Zelm, Menno C ^c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

B cells; Costimulation; Dendritic cells; T cells

Indexed keywords

CD27 ANTIGEN; CD70 ANTIGEN; INTERFERON; INTERLEUKIN 15; INTERLEUKIN 7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CROSS PRESENTATION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MEMORY T LYMPHOCYTE; MONOCYTE; NONHUMAN; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; VIRUS INFECTION; ANIMAL; CELL COMMUNICATION; CYTOLOGY; GENE REARRANGEMENT; HELPER CELL; IMMUNOLOGY; PHYSIOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; B-LYMPHOCYTES; CELL COMMUNICATION; DENDRITIC CELLS; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84912121097     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.10.011     Document Type: Review

References (214)

1. Tacken P.J., de Vries I.J., Torensma R., Figdor C.G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol 2007, 7:790-802.
2. Melief C.J. Cancer immunotherapy by dendritic cells. Immunity 2008, 29:372-383.
3. Mosier D.E., Coppleson L.W. A three-cell interaction required for the induction of the primary immune response in vitro. Proc Natl Acad Sci U S A 1968, 61:542-547.
4. Cosenza H., Leserman L.D., Rowley D.A. The third cell type required for the immune response of spleen cells in vitro. J Immunol 1971, 107:414-421.
5. Steinman R.M., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973, 137:1142-1162.
6. Steinman R.M., Witmer M.D. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc Natl Acad Sci U S A 1978, 75:5132-5136.
7. Veerman A.J. On the interdigitating cells in the thymus-dependent area of the rat spleen: a relation between the mononuclear phagocyte system and T-lymphocytes. Cell Tissue Res 1974, 148:247-257.
8. Hoefsmit E.C., Duijvestijn A.M., Kamperdijk E.W. Relation between langerhans cells, veiled cells, and interdigitating cells. Immunobiology 1982, 161:255-265.
9. Dijkstra C.D., Dopp E.A., Joling P., Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985, 54:589-599.
10. Kraal G., Breel M., Janse M., Bruin G. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J Exp Med 1986, 163:981-997.
11. Leenen P.J., de Bruijn M.F., Voerman J.S., Campbell P.A., van E.W. Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods 1994, 174:5-19.
12. Lechler R.I., Batchelor J.R. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982, 155:31-41.
13. Boog C.J., Kast W.M., Timmers H.T., Boes J., de Waal L.P., Melief C.J. Abolition of specific immune response defect by immunization with dendritic cells. Nature 1985, 318:59-62.
14. Jung S., Unutmaz D., Wong P., Sano G., De los S.K., Sparwasser T., et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 2002, 17:211-220.
15. Schraml B.U., van B.J., Zelenay S., Whitney P.G., Filby A., Acton S.E., et al. Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. Cell 2013, 154:843-858.
16. Naik S.H., Perie L., Swart E., Gerlach C., van R.N., de Boer R.J., et al. Diverse and heritable lineage imprinting of early haematopoietic progenitors. Nature 2013, 496:229-232.
17. Neefjes J., Jongsma M.L., Paul P., Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 2011, 11:823-836.
18. Vyas J.M., Van der Veen A.G., Ploegh H.L. The known unknowns of antigen processing and presentation. Nat Rev Immunol 2008, 8:607-618.
19. Bevan M.J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 1976, 143:1283-1288.
20. Neefjes J., Sadaka C. Into the intracellular logistics of cross-presentation. Front Immunol 2012, 3:31.
21. Joffre O.P., Segura E., Savina A., Amigorena S. Cross-presentation by dendritic cells. Nat Rev Immunol 2012, 12:557-569.
22. Delamarre L., Pack M., Chang H., Mellman I., Trombetta E.S. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 2005, 307:1630-1634.
23. van Montfoort N., Camps M.G., Khan S., Filippov D.V., Weterings J.J., Griffith J.M., et al. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proc Natl Acad Sci U S A 2009, 106:6730-6735.
24. ten Broeke T., Wubbolts R., Stoorvogel W. MHC class II antigen presentation by dendritic cells regulated through endosomal sorting. Cold Spring Harb Perspect Biol 2013, 5:a016873.
25. Mildner A., Jung S. Development and function of dendritic cell subsets. Immunity 2014, 40:642-656.
26. Merad M., Sathe P., Helft J., Miller J., Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013, 31:563-604.
27. Sathe P., Metcalf D., Vremec D., Naik S.H., Langdon W.Y., Huntington N.D., et al. Lymphoid tissue and plasmacytoid dendritic cells and macrophages do not share a common macrophage-dendritic cell-restricted progenitor. Immunity 2014, 41:104-115.
28. Murphy K.M. Transcriptional control of dendritic cell development. Adv Immunol 2013, 120:239-267.
29. Beijer M.R., Kraal G., den Haan J.M. Vitamin A and dendritic cell differentiation. Immunology 2014, 142:39-45.
30. Serbina N.V., Salazar-Mather T.P., Biron C.A., Kuziel W.A., Pamer E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59-70.
31. Cheong C., Matos I., Choi J.H., Dandamudi D.B., Shrestha E., Longhi M.P., et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 2010, 143:416-429.
32. Reis E., Sousa C., Hieny S., Scharton-Kersten T., Jankovic D., Charest H., et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med 1997, 186:1819-1829.
33. den Haan J.M., Lehar S.M., Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 2000, 192:1685-1696.
34. Dudziak D., Kamphorst A.O., Heidkamp G.F., Buchholz V.R., Trumpfheller C., Yamazaki S., et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007, 315:107-111.
35. Edelson B.T., Kc W., Juang R., Kohyama M., Benoit L.A., Klekotka P.A., et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J Exp Med 2010, 207:823-836.
36. Hildner K., Edelson B.T., Purtha W.E., Diamond M., Matsushita H., Kohyama M., et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008, 322:1097-1100.
37. Schlitzer A., McGovern N., Teo P., Zelante T., Atarashi K., Low D., et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 2013, 38:970-983.
38. Gatto D., Wood K., Caminschi I., Murphy-Durland D., Schofield P., Christ D., et al. The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells. Nat Immunol 2013, 14:446-453.
39. Yi T., Cyster J.G. EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture. Elife (Cambridge) 2013, 2:e00757.
40. Chappell C.P., Draves K.E., Giltiay N.V., Clark E.A. Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses. J Exp Med 2012, 209:1825-1840.
41. Bergtold A., Desai D.D., Gavhane A., Clynes R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 2005, 23:503-514.
42. Xu W., Banchereau J. The antigen presenting cells instruct plasma cell differentiation. Front Immunol 2014, 4:504.
43. Martinez-Pomares L., Gordon S. CD169+ macrophages at the crossroads of antigen presentation. Trends Immunol 2012, 33:66-70.
44. van Helden M.J., Lambrecht B.N. Dendritic cells in asthma. Curr Opin Immunol 2013, 25:745-754.
45. Satpathy A.T., Briseno C.G., Lee J.S., Ng D., Manieri N.A., Kc W., et al. Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat Immunol 2013, 14:937-948.
46. Van Voorhis W.C., Hair L.S., Steinman R.M., Kaplan G. Human dendritic cells. Enrichment and characterization from peripheral blood. J Exp Med 1982, 155:1172-1187.
47. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994, 179:1109-1118.
48. Kalinski P., Hilkens C.M., Wierenga E.A., Kapsenberg M.L. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 1999, 20:561-567.
49. van Kooten C., Gelderman K.A. In vitro-generated DC with tolerogenic functions: perspectives for in vivo cellular therapy. Methods Mol Biol 2011, 677:149-159.
50. de Jong E.C., Vieira P.L., Kalinski P., Kapsenberg M.L. Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J Leukoc Biol 1999, 66:201-204.
51. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
52. Geijtenbeek T.B., Torensma R., van Vliet S.J., van Duijnhoven G.C., Adema G.J., van K.Y., et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100:575-585.
53. Figdor C.G., de Vries I.J., Lesterhuis W.J., Melief C.J. Dendritic cell immunotherapy: mapping the way. Nat Med 2004, 10:475-480.
54. de Gruijl T.D., van den Eertwegh A.J., Pinedo H.M., Scheper R.J. Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines. Cancer Immunol Immunother 2008, 57:1569-1577.
55. Blom B., Spits H. Development of human lymphoid cells. Annu Rev Immunol 2006, 24:287-320.
56. Tel J., van der Leun A.M., Figdor C.G., Torensma R., de Vries I.J. Harnessing human plasmacytoid dendritic cells as professional APCs. Cancer Immunol Immunother 2012, 61:1279-1288.
57. Schlitzer A., Ginhoux F. Organization of the mouse and human DC network. Curr Opin Immunol 2014, 26:90-99.
58. Haniffa M., Collin M., Ginhoux F. Ontogeny and functional specialization of dendritic cells in human and mouse. Adv Immunol 2013, 120:1-49.
59. Villadangos J.A., Shortman K. Found in translation: the human equivalent of mouse CD8+ dendritic cells. J Exp Med 2010, 207:1131-1134.
60. Segura E., Amigorena S. Cross-presentation by human dendritic cell subsets. Immunol Lett 2014, 158:73-78.
61. Love P.E., Bhandoola A. Signal integration and crosstalk during thymocyte migration and emigration. Nat Rev Immunol 2011, 11:469-477.
62. Surh C.D., Sprent J. Homeostasis of naive and memory T cells. Immunity 2008, 29:848-862.
63. Williams M.A., Bevan M.J. Effector and memory CTL differentiation. Annu Rev Immunol 2007, 25:171-192.
64. Arens R., Schoenberger S.P. Plasticity in programming of effector and memory CD8 T-cell formation. Immunol Rev 2010, 235:190-205.
65. Curtsinger J.M., Mescher M.F. Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol 2010, 22:333-340.
66. Probst H.C., van den Broek M. Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells. J Immunol 2005, 174:3920-3924.
67. Henrickson S.E., Perro M., Loughhead S.M., Senman B., Stutte S., Quigley M., et al. Antigen availability determines CD8(+) T cell-dendritic cell interaction kinetics and memory fate decisions. Immunity 2013, 39:496-507.
68. Swain S.L., McKinstry K.K., Strutt T.M. Expanding roles for CD4(+) T cells in immunity to viruses. Nat Rev Immunol 2012, 12:136-148.
69. Soghoian D.Z., Streeck H. Cytolytic CD4(+) T cells in viral immunity. Expert Rev Vaccines 2010, 9:1453-1463.
70. Brown D.M. Cytolytic CD4 cells: direct mediators in infectious disease and malignancy. Cell Immunol 2010, 262:89-95.
71. Shrikant P.A., Rao R., Li Q., Kesterson J., Eppolito C., Mischo A., et al. Regulating functional cell fates in CD8 T cells. Immunol Res 2010, 46:12-22.
72. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
73. Mueller S.N., Gebhardt T., Carbone F.R., Heath W.R. Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol 2013, 31:137-161.
74. Ariotti S., Beltman J.B., Chodaczek G., Hoekstra M.E., van Beek A.E., Gomez-Eerland R., et al. Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen. Proc Natl Acad Sci U S A 2012, 109:19739-19744.
75. Jenkins M.K., Moon J.J. The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude. J Immunol 2012, 188:4135-4140.
76. Moon J.J., Chu H.H., Pepper M., McSorley S.J., Jameson S.C., Kedl R.M., et al. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 2007, 27:203-213.
77. Obar J.J., Khanna K.M., Lefrancois L. Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. Immunity 2008, 28:859-869.
78. Kaech S.M., Wherry E.J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002, 2:251-262.
79. Schepers K., Swart E., van Heijst J.W., Gerlach C., Castrucci M., Sie D., et al. Dissecting T cell lineage relationships by cellular barcoding. J Exp Med 2008, 205:2309-2318.
80. Gerlach C., van Heijst J.W., Swart E., Sie D., Armstrong N., Kerkhoven R.M., et al. One naive T cell, multiple fates in CD8+ T cell differentiation. J Exp Med 2010, 207:1235-1246.
81. Gerlach C., Rohr J.C., Perie L., van R.N., van Heijst J.W., Velds A., et al. Heterogeneous differentiation patterns of individual CD8+ T cells. Science 2013, 340:635-639.
82. Plumlee C.R., Sheridan B.S., Cicek B.B., Lefrancois L. Environmental cues dictate the fate of individual CD8+ T cells responding to infection. Immunity 2013, 39:347-356.
83. Stemberger C., Huster K.M., Koffler M., Anderl F., Schiemann M., Wagner H., et al. A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets. Immunity 2007, 27:985-997.
84. Buchholz V.R., Flossdorf M., Hensel I., Kretschmer L., Weissbrich B., Graf P., et al. Disparate individual fates compose robust CD8+ T cell immunity. Science 2013, 340:630-635.
85. Arsenio J., Kakaradov B., Metz P.J., Kim S.H., Yeo G.W., Chang J.T. Early specification of CD8+ T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses. Nat Immunol 2014, 15:365-372.
86. Tubo N.J., Pagan A.J., Taylor J.J., Nelson R.W., Linehan J.L., Ertelt J.M., et al. Single naive CD4+ T cells from a diverse repertoire produce different effector cell types during infection. Cell 2013, 153:785-796.
87. Fearon D.T., Manders P., Wagner S.D. Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 2001, 293:248-250.
88. Gattinoni L., Lugli E., Ji Y., Pos Z., Paulos C.M., Quigley M.F., et al. A human memory T cell subset with stem cell-like properties. Nat Med 2011, 17:1290-1297.
89. Lugli E., Dominguez M.H., Gattinoni L., Chattopadhyay P.K., Bolton D.L., Song K., et al. Superior T memory stem cell persistence supports long-lived T cell memory. J Clin Invest 2013, 123:594-599.
90. Gattinoni L., Zhong X.S., Palmer D.C., Ji Y., Hinrichs C.S., Yu Z., et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med 2009, 15:808-813.
91. Zhang Y., Joe G., Hexner E., Zhu J., Emerson S.G. Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat Med 2005, 11:1299-1305.
92. Graef P., Buchholz V.R., Stemberger C., Flossdorf M., Henkel L., Schiemann M., et al. Serial transfer of single-cell-derived immunocompetence reveals stemness of CD8(+) central memory T cells. Immunity 2014, 41:116-126.
93. Kumar R., Ferez M., Swamy M., Arechaga I., Rejas M.T., Valpuesta J.M., et al. Increased sensitivity of antigen-experienced T cells through the enrichment of oligomeric T cell receptor complexes. Immunity 2011, 35:375-387.
94. Gett A.V., Sallusto F., Lanzavecchia A., Geginat J. T cell fitness determined by signal strength. Nat Immunol 2003, 4:355-360.
95. van Stipdonk M.J., Hardenberg G., Bijker M.S., Lemmens E.E., Droin N.M., Green D.R., et al. Dynamic programming of CD8+ T lymphocyte responses. Nat Immunol 2003, 4:361-365.
96. Blair D.A., Turner D.L., Bose T.O., Pham Q.M., Bouchard K.R., Williams K.J., et al. Duration of antigen availability influences the expansion and memory differentiation of T cells. J Immunol 2011, 187:2310-2321.
97. Savage P.A., Boniface J.J., Davis M.M. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 1999, 10:485-492.
98. Busch D.H., Pamer E.G. T cell affinity maturation by selective expansion during infection. J Exp Med 1999, 189:701-710.
99. Slifka M.K., Whitton J.L. Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat Immunol 2001, 2:711-717.
100. Zehn D., Lee S.Y., Bevan M.J. Complete but curtailed T-cell response to very low-affinity antigen. Nature 2009, 458:211-214.
101. Wensveen F.M., van Gisbergen K.P., Derks I.A., Gerlach C., Schumacher T.N., van Lier R.A., et al. Apoptosis threshold set by Noxa and Mcl-1 after T cell activation regulates competitive selection of high-affinity clones. Immunity 2010, 32:754-765.
102. Pace L., Tempez A., Arnold-Schrauf C., Lemaitre F., Bousso P., Fetler L., et al. Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory. Science 2012, 338:532-536.
103. Kim C., Wilson T., Fischer K.F., Williams M.A. Sustained interactions between T cell receptors and antigens promote the differentiation of CD4(+) memory T cells. Immunity 2013, 39:508-520.
104. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?. Nat Rev Immunol 2003, 3:609-620.
105. Wherry E.J., Ha S.J., Kaech S.M., Haining W.N., Sarkar S., Kalia V., et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007, 27:670-684.
106. Driessens G., Kline J., Gajewski T.F. Costimulatory and coinhibitory receptors in anti-tumor immunity. Immunol Rev 2009, 229:126-144.
107. Arens R. Rational design of vaccines: learning from immune evasion mechanisms of persistent viruses and tumors. Adv Immunol 2012, 114:217-243.
108. Pardoll D.M. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012, 12:252-264.
109. Croft M., Benedict C.A., Ware C.F. Clinical targeting of the TNF and TNFR superfamilies. Nat Rev Drug Discov 2013, 12:147-168.
110. Welten S.P., Melief C.J., Arens R. The distinct role of T cell costimulation in antiviral immunity. Curr Opin Virol 2013, 3:475-482.
111. O'Hara G.A., Welten S.P., Klenerman P., Arens R. Memory T cell inflation: understanding cause and effect. Trends Immunol 2012, 33:84-90.
112. Arens R., Loewendorf A., Redeker A., Sierro S., Boon L., Klenerman P., et al. Differential B7-CD28 costimulatory requirements for stable and inflationary mouse cytomegalovirus-specific memory CD8 T cell populations. J Immunol 2011, 186:3874-3881.
113. Humphreys I.R., Loewendorf A., de T.C., Schneider K., Benedict C.A., Munks M.W., et al. OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T cells: a CD4-dependent mechanism. J Immunol 2007, 179:2195-2202.
114. Humphreys I.R., Lee S.W., Jones M., Loewendorf A., Gostick E., Price D.A., et al. Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8(+) T cells. Eur J Immunol 2010, 40:2762-2768.
115. Welten S.P., Redeker A., Franken K.L., Benedict C.A., Yagita H., Wensveen F.M., et al. CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection. J Virol 2013, 87:6851-6865.
116. Hendriks J., Gravestein L.A., Tesselaar K., van Lier R.A., Schumacher T.N., Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 2000, 1:433-440.
117. Arens R., Tesselaar K., Baars P.A., van Schijndel G.M., Hendriks J., Pals S.T., et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 2001, 15:801-812.
118. Tesselaar K., Arens R., van Schijndel G.M., Baars P.A., van der Valk M.A., Borst J., et al. Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nat Immunol 2003, 4:49-54.
119. Arens R., Schepers K., Nolte M.A., van Oosterwijk M.F., van Lier R.A., Schumacher T.N., et al. Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation. J Exp Med 2004, 199:1595-1605.
120. Arens R., Baars P.A., Jak M., Tesselaar K., van d V., van Oers M.H., et al. Cutting edge: CD95 maintains effector T cell homeostasis in chronic immune activation. J Immunol 2005, 174:5915-5920.
121. van Gisbergen K.P., van Olffen R.W., van B.J., van der Sluijs K.F., Arens R., Nolte M.A., et al. Protective CD8 T cell memory is impaired during chronic CD70-driven costimulation. J Immunol 2009, 182:5352-5362.
122. Peperzak V., Xiao Y., Veraar E.A., Borst J. CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production. J Clin Invest 2010, 120:168-178.
123. Coquet J.M., Middendorp S., van der Horst G., Kind J., Veraar E.A., Xiao Y., et al. The CD27 and CD70 costimulatory pathway inhibits effector function of T helper 17 cells and attenuates associated autoimmunity. Immunity 2013, 38:53-65.
124. Duttagupta P.A., Boesteanu A.C., Katsikis P.D. Costimulation signals for memory CD8+ T cells during viral infections. Crit Rev Immunol 2009, 29:469-486.
125. Agarwal P., Raghavan A., Nandiwada S.L., Curtsinger J.M., Bohjanen P.R., Mueller D.L., et al. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J Immunol 2009, 183:1695-1704.
126. Joshi N.S., Cui W., Chandele A., Lee H.K., Urso D.R., Hagman J., et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 2007, 27:281-295.
127. Wiesel M., Crouse J., Bedenikovic G., Sutherland A., Joller N., Oxenius A. Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo. Eur J Immunol 2012, 42:320-329.
128. Richer M.J., Nolz J.C., Harty J.T. Pathogen-specific inflammatory milieux tune the antigen sensitivity of CD8(+) T cells by enhancing T cell receptor signaling. Immunity 2013, 38:140-152.
129. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998, 393:480-483.
130. Bevan M.J. Helping the CD8(+) T-cell response. Nat Rev Immunol 2004, 4:595-602.
131. Wiesel M., Oxenius A. From crucial to negligible: functional CD8(+) T-cell responses and their dependence on CD4(+) T-cell help. Eur J Immunol 2012, 42:1080-1088.
132. Wiesel M., Kratky W., Oxenius A. Type I IFN substitutes for T cell help during viral infections. J Immunol 2011, 186:754-763.
133. Tough D.F., Borrow P., Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996, 272:1947-1950.
134. Ben-Sasson S.Z., Hu-Li J., Quiel J., Cauchetaux S., Ratner M., Shapira I., et al. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci U S A 2009, 106:7119-7124.
135. Malek T.R. The biology of interleukin-2. Annu Rev Immunol 2008, 26:453-479.
136. Boyman O., Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 2012, 12:180-190.
137. Williams M.A., Tyznik A.J., Bevan M.J. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 2006, 441:890-893.
138. Bachmann M.F., Wolint P., Walton S., Schwarz K., Oxenius A. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections. Eur J Immunol 2007, 37:1502-1512.
139. Feau S., Arens R., Togher S., Schoenberger S.P. Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells. Nat Immunol 2011, 12:908-913.
140. Kalia V., Sarkar S., Subramaniam S., Haining W.N., Smith K.A., Ahmed R. Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 2010, 32:91-103.
141. Pipkin M.E., Sacks J.A., Cruz-Guilloty F., Lichtenheld M.G., Bevan M.J., Rao A. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 2010, 32:79-90.
142. Lam K.P., Kuhn R., Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997, 90:1073-1083.
143. Torres R.M., Flaswinkel H., Reth M., Rajewsky K., Aberrant B. cell development and immune response in mice with a compromised BCR complex. Science 1996, 272:1804-1808.
144. Srinivasan L., Sasaki Y., Calado D.P., Zhang B., Paik J.H., DePinho R.A., et al. PI3 kinase signals BCR-dependent mature B cell survival. Cell 2009, 139(3):573-586.
145. Engelman J.A., Luo J., Cantley L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev 2006, 7:606-619.
146. Mackay F., Schneider P., Rennert P., Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 2003, 21:231-264.
147. Dillon S.R., Gross J.A., Ansell S.M., Novak A.J. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 2006, 5:235-246.
148. Gross J.A., Dillon S.R., Mudri S., Johnston J., Littau A., Roque R., et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity 2001, 15:289-302.
149. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001, 293:2111-2114.
150. Warnatz K., Salzer U., Rizzi M., Fischer B., Gutenberger S., Bohm J., et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009, 106:13945-13950.
151. van Zelm M.C., Szczepanski T., van der Burg M., van Dongen J.J. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med 2007, 204:645-655.
152. Calandra T., Bernhagen J., Mitchell R.A., Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994, 179:1895-1902.
153. George M., Vaughan J.H. In vitro cell migration as a model for delayed hypersensitivity. Proc Soc Exp Biol Med (New York, NY) 1962, 111:514-521.
154. Sapoznikov A., Pewzner-Jung Y., Kalchenko V., Krauthgamer R., Shachar I., Jung S. Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nat Immunol 2008, 9:388-395.
155. Gore Y., Starlets D., Maharshak N., Becker-Herman S., Kaneyuki U., Leng L., et al. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J Biol Chem 2008, 283:2784-2792.
156. Matza D., Lantner F., Bogoch Y., Flaishon L., Hershkoviz R., Shachar I. Invariant chain induces B cell maturation in a process that is independent of its chaperonic activity. Proc Natl Acad Sci U S A 2002, 99:3018-3023.
157. Shachar I., Flavell R.A. Requirement for invariant chain in B cell maturation and function. Science 1996, 274:106-108.
158. Ales-Martinez J.E., Warner G.L., Scott D.W. Immunoglobulins D and M mediate signals that are qualitatively different in B cells with an immature phenotype. Proc Natl Acad Sci U S A 1988, 85:6919-6923.
159. Peckham D., Andersen-Nissen E., Finkelman F.D., Stunz L.L., Ashman R.F. Difference in apoptosis induction between surface IgD and IgM. Int Immunol 2001, 13:285-295.
160. Chaturvedi A., Siddiqui Z., Bayiroglu F., Rao K.V. A GPI-linked isoform of the IgD receptor regulates resting B cell activation. Nat Immunol 2002, 3:951-957.
161. Wienands J., Reth M. Glycosyl-phosphatidylinositol linkage as a mechanism for cell-surface expression of immunoglobulin D. Nature 1992, 356:246-248.
162. Nitschke L., Kosco M.H., Kohler G., Lamers M.C. Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens. Proc Natl Acad Sci U S A 1993, 90:1887-1891.
163. Roes J., Rajewsky K. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. J Exp Med 1993, 177:45-55.
164. van Zelm M.C., Reisli I., van der Burg M., Castaño D., van Noesel C.J.M., van Tol M.J.D., et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006, 354:1901-1912.
165. van Zelm M.C., Smet J., Adams B., Mascart F., Schandene L., Janssen F., et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 2010, 120:1265-1274.
166. Thiel J., Kimmig L., Salzer U., Grudzien M., Lebrecht D., Hagena T., et al. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol 2012, 129:801-810.
167. Carter R.H., Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992, 256:105-107.
168. van Noesel C.J., Lankester A.C., van Lier R.A. Dual antigen recognition by B cells. Immunol Today 1993, 14:8-11.
169. Fearon D.T., Carroll M.C. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 2000, 18:393-422.
170. Cherukuri A., Cheng P.C., Sohn H.W., Pierce S.K. The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity 2001, 14:169-179.
171. Bretscher P., Cohn M. A theory of self-nonself discrimination. Science 1970, 169:1042-1049.
172. MacLennan I.C. Germinal centers. Annu Rev Immunol 1994, 12:117-139.
173. Durandy A., Kracker S., Fischer A. Primary antibody deficiencies. Nat Rev Immunol 2013, 13:519-533.
174. van Zelm M.C., Bartol S.J., Driessen G.J., Mascart F., Reisli I., Franco J.L., et al. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation. J Allergy Clin Immunol 2014, 134:135-144.
175. Grimbacher B., Hutloff A., Schlesier M., Glocker E., Warnatz K., Drager R., et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003, 4:261-268.
176. Warnatz K., Bossaller L., Salzer U., Skrabl-Baumgartner A., Schwinger W., van der Burg M., et al. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 2006, 107:3045-3052.
177. Choi Y.S., Kageyama R., Eto D., Escobar T.C., Johnston R.J., Monticelli L., et al. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 2011, 34:932-946.
178. Bossaller L., Burger J., Draeger R., Grimbacher B., Knoth R., Plebani A., et al. ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J Immunol 2006, 177:4927-4932.
179. Good-Jacobson K.L., Szumilas C.G., Chen L., Sharpe A.H., Tomayko M.M., Shlomchik M.J. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat Immunol 2010, 11:535-542.
180. Kawamoto S., Tran T.H., Maruya M., Suzuki K., Doi Y., Tsutsui Y., et al. The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut. Science 2012, 336:485-489.
181. Suvas S., Singh V., Sahdev S., Vohra H., Agrewala J.N. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J Biol Chem 2002, 277:7766-7775.
182. Jeannin P., Delneste Y., Lecoanet-Henchoz S., Gauchat J.F., Ellis J., Bonnefoy J.Y. CD86 (B7-2) on human B cells. A functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells. J Biol Chem 1997, 272:15613-15619.
183. Walker L.S., Sansom D.M. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat Rev Immunol 2011, 11:852-863.
184. Kuehn H.S., Ouyang W., Lo B., Deenick E.K., Niemela J.E., Avery D.T., et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 2014, 345:1623-1627.
185. Cannons J.L., Qi H., Lu K.T., Dutta M., Gomez-Rodriguez J., Cheng J., et al. Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 2010, 32:253-265.
186. Ma C.S., Nichols K.E., Tangye S.G. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu Rev Immunol 2007, 25:337-379.
187. Eto D., Lao C., DiToro D., Barnett B., Escobar T.C., Kageyama R., et al. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS ONE 2011, 6:e17739.
188. Karnowski A., Chevrier S., Belz G.T., Mount A., Emslie D., D'Costa K., et al. B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1. J Exp Med 2012, 209:2049-2064.
189. Recher M., Berglund L.J., Avery D.T., Cowan M.J., Gennery A.R., Smart J., et al. IL-21 is the primary common gamma chain-binding cytokine required for human B-cell differentiation in vivo. Blood 2011, 118:6824-6835.
190. Pene J., Gauchat J.F., Lecart S., Drouet E., Guglielmi P., Boulay V., et al. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J Immunol 2004, 172:5154-5157.
191. Avery D.T., Bryant V.L., Ma C.S., de Waal M.R., Tangye S.G. IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J Immunol 2008, 181:1767-1779.
192. Briere F., Servet-Delprat C., Bridon J.M., Saint-Remy J.M., Banchereau J. Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. J Exp Med 1994, 179:757-762.
193. Pene J., Rousset F., Briere F., Chretien I., Paliard X., Banchereau J., et al. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma. J Immunol 1988, 141:1218-1224.
194. Lundgren M., Persson U., Larsson P., Magnusson C., Smith C.I., Hammarstrom L., et al. Interleukin 4 induces synthesis of IgE and IgG4 in human B cells. Eur J Immunol 1989, 19:1311-1315.
195. Islam K.B., Nilsson L., Sideras P., Hammarstrom L., Smith C.I. TGF-beta 1 induces germ-line transcripts of both IgA subclasses in human B lymphocytes. Int Immunol 1991, 3:1099-1106.
196. Mond J.J., Vos Q., Lees A., Snapper C.M. T cell independent antigens. Curr Opin Immunol 1995, 7:349-354.
197. Delgado M.F., Coviello S., Monsalvo A.C., Melendi G.A., Hernandez J.Z., Batalle J.P., et al. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 2009, 15:34-41.
198. Weller S., Faili A., Garcia C., Braun M.C., Le Deist F.F., de Saint Basile G.G., et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci U S A 2001, 98:1166-1170.
199. He B., Santamaria R., Xu W., Cols M., Chen K., Puga I., et al. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol 2010, 11:836-845.
200. He B., Xu W., Santini P.A., Polydorides A.D., Chiu A., Estrella J., et al. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 2007, 26:812-826.
201. Fayette J., Dubois B., Vandenabeele S., Bridon J.M., Vanbervliet B., Durand I., et al. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J Exp Med 1997, 185:1909-1918.
202. Wykes M., Pombo A., Jenkins C., MacPherson G.G. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol 1998, 161:1313-1319.
203. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002, 3:822-829.
204. Cerutti A. The regulation of IgA class switching. Nat Rev Immunol 2008, 8:421-434.
205. Weill J.C., Weller S., Reynaud C.A. Human marginal zone B cells. Annu Rev Immunol 2009, 27:267-285.
206. Puga I., Cols M., Barra C.M., He B., Cassis L., Gentile M., et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 2012, 13:170-180.
207. Magri G., Miyajima M., Bascones S., Mortha A., Puga I., Cassis L., et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol 2014, 15:354-364.
208. Mestecky J., Russell M.W., Elson C.O. Intestinal IgA: novel views on its function in the defence of the largest mucosal surface. Gut 1999, 44:2-5.
209. Ahmed R., Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996, 272:54-60.
210. Agematsu K., Nagumo H., Yang F.C., Nakazawa T., Fukushima K., Ito S., et al. B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol 1997, 27:2073-2079.
211. Berkowska M.A., Driessen G.J., Bikos V., Grosserichter-Wagener C., Stamatopoulos K., Cerutti A., et al. Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood 2011, 118:2150-2158.
212. Berkowska M.A., Heeringa J.J., Hajdarbegovic E., van der Burg M., Thio H.B., van Hagen P.M., et al. Human IgE B cells are derived from T cell-dependent and T cell-independent pathways. J Allergy Clin Immunol 2014, 134:688-697.
213. Tangye S.G., Avery D.T., Deenick E.K., Hodgkin P.D. Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses. J Immunol 2003, 170:686-694.
214. Good K.L., Avery D.T., Tangye S.G. Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol 2009, 182:890-901.